A new data visualisation showing the results of 106 clinical trials in multiple sclerosis over the past 30 years reveals possible publication bias. The tool was developed by the Multiple Sclerosis Discovery Forum (MSDF) and is the first in a series of visualisations they are creating in the hope that people will discover unexpected […]
Many signatories to AllTrials have wondered why the World Health Organisation has never had a policy on reporting the results of clinical trials. The WHO has now resolved that it needs one.
It is seeking public comments on a draft statement, which you can find here.
This is potentially a really significant step. We have a chance […]
More researchers will post the results of their trials if they are sent an email reminder according to a recent study published in The BMJ. Since 2007, the FDA has required people in the US to register their trials on ClinicalTrials.gov before they begin and to post summary results within one year of completion […]
Ian Burgess told us about two trials on head lice treatments that had been kept hidden for 14 and 20 years. These trials involved 546 people (mostly children) in Bangladesh and the UK. Dr Burgess’ group managed to publish both of the trials this year in open access journals.
I have been wanting to publish […]
One of Italy’s largest newspapers, Corriere della Sera, has posted a video with interviews about the AllTrials campaign. The video features Nino Cartabellotta, President of the GIMBE Foundation, and Silvio Garattini, Director of the Mario Negri Institute for Pharmacological Research.
GIMBE is an Italian academic organisation that promotes evidence-based medicine. They joined the AllTrials campaign in […]
Please respond today to the Faculty of Pharmaceutical Medicine’s (FPM) consultation on whether it should tell its members they must register and report all clinical trials. The FPM represents doctors who develop and monitor the safety of medicines and medical devices. Its members work for academic institutes, regulators and pharmaceutical companies in the UK […]
Yesterday, the likely European Commissioner for industry who will oversee the regulation of medicines and the EMA said there are risks that need to be balanced with greater clinical trial transparency. MEPs have been questioning the candidates for the new European Commission and, if approved by MEPs, Elżbieta Bieńkowska will lead the industry department […]
After pressure from citizens and scientists the European Medicines Agency has agreed to scrap restrictions on clinical trial data sharing that would have made independent scrutiny of the data impossible.
Hundreds of citizens and organisations representing thousands of people across Europe have been asking the EMA to overturn a rule that would have allowed researchers […]
Today Europe’s medicines body votes on how much clinical trial information it will allow researchers to see. The European Medicines Agency promised in 2010 to give researchers greater access to the clinical trial data it holds. But its published policy on how it will share this data would effectively prevent independent researchers from being able to evaluate the benefits and […]
In May 2014 Tom Treasure and his colleagues were able to publish the results of a trial completed 20 years ago involving 1447 bowel cancer patients. It was the first trial to be published under the RIAT (restoring invisible and abandoned trials) initiative announced last year.
Few people lived more than 5 years after being […]